FDA Novel Drug Approvals

FDA CDER novel drug approvals by year: drug name, active ingredient, approval date, use/indication, and sponsor company. Official FDA pages — company facts only, no patient data. Unofficial; not affiliated with the FDA.

Publisher description, verbatim
Last 7 dayson this actor
Each one reaches followers by email the morning after.Follow this actor
Key figures0 readings
Price / 1k$4.99per 1,000 results
Users / 30d1not enough history for a trend
Users, all time2not enough history for a trend
Runs / 30d0not enough history for a trend
Runs / user / mo—runs per monthly user
Standing
#7of 64

on U.S. Food and Drug Administration, by users in the last 30 days among actors classified to this platform.

Recorded changes
  • 2026-09-25changeListed—on record
showing 1 of 1 in the last 30 days · followers get the next one by email

Alternatives on U.S. Food and Drug Administration

The actors either side of #7 of 64, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 64 on U.S. Food and Drug Administration →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
2—RES$9.00 /1ksteep price23 total——3maging
3—EVT$21.00 /1k result-item27 total——4mfresh
4—EVT$10.00 /1k watch-target-check12 total——12dfresh
5—EVT$10.00 /1k supplier_checked12 total——20dfresh
6—RES$5.00 /1kgood price12 total——6dfresh
7—RES$4.99 /1kgood price12 total——3dfreshThis
8—RES$5.00 /1kgood price14 total——10mfresh
9—FREEfree12 total——3maging
10—RES$5.00 /1kgood price12 total——3maging
11—RES$5.00 /1kgood price12 total——3maging
12—EVT$30.00 /1k search-run12 total——7dfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.